Devan Shah and Namita Bisaria, experts in the field of RNA therapies, discuss the year ahead in RNA - opportunities, challenges, AI, fundraising, and more
- Author
- BiotechTV
- Published
- Mon 24 Feb 2025
- Episode Link
- https://podcasters.spotify.com/pod/show/biotechtv8/episodes/Devan-Shah-and-Namita-Bisaria--experts-in-the-field-of-RNA-therapies--discuss-the-year-ahead-in-RNA---opportunities--challenges--AI--fundraising--and-more-e2vaj3t
Devan Shah, Founder & CEO of RNAV8 Bio, and Namita Bisaria, Head of Research, Strategy, and Operations at AIRNA, discusses approaches to RNA they are excited about this year, companies that have impressed them, and challenges ahead. They touch on uncertainties regarding the regulatory environment, how they think AI might, or might not, affect the field, and more.
